Roche's Alzheimer’s Drug Trial and U.S. Health Data Initiative Making Headlines
Published on: July 28, 2025, 10:33 a.m. | Source: Devdiscourse
Swiss company Roche Holding plans to test a new drug, Trontinemab, aiming to delay or prevent Alzheimer's. Meanwhile, U.S. health officials and tech executives are set to discuss a plan for more efficient health data sharing at an event led by key Trump administration figures.
